Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Jul;94(1):136-41.
doi: 10.3945/ajcn.110.004549. Epub 2011 May 18.

Long-term effect of low-dose folic acid intake: potential effect of mandatory fortification on the prevention of neural tube defects

Affiliations
Randomized Controlled Trial

Long-term effect of low-dose folic acid intake: potential effect of mandatory fortification on the prevention of neural tube defects

Lisa A Houghton et al. Am J Clin Nutr. 2011 Jul.

Abstract

Background: Understanding the full effect of chronic low-dose folic acid is important in interpreting the effect of the mandatory folic acid fortification program in North America.

Objective: We aimed to describe the rate of attainment and steady state (plateau) of red blood cell (RBC) folate in response to long-term intake of 140 μg (designed to mimic fortification) and 400 μg (recommended dose for the primary prevention of neural tube defects) folic acid/d in reproductive-aged women living in a country with minimal fortification.

Design: On the basis of pharmacokinetics principles, it was recently proposed that a steady state should be reached after 40 wk. Thus, 144 women aged 18-40 y were randomly assigned to receive a daily folic acid supplement of 140 (n = 49) or 400 (n = 48) μg or placebo (n = 47) for 40 wk. RBC folate was measured at baseline and at 6, 12, 29, and 40 wk.

Results: After 40 wk, RBC folate did not reach a plateau in either treatment group. Kinetic modeling of the data indicated that RBC folate would approximately double from 779 to 1356 nmol/L in response to 140 μg folic acid/d with only ≈50% of model-estimated steady state conditions achieved at 40 wk. An average RBC folate concentration of 1068 nmol/L after 12 wk of supplementation with 400 μg folic acid/d was readily achieved at 36 wk after continuous intake of 140 μg/d.

Conclusion: Our model shows the considerable length of time required to attain the full effect of low-dose folic acid, which suggests that 140 μg folic acid/d could be as effective as 400 μg folic acid/d taken during the periconceptional period if given sufficient time. This trial is registered at www.anzctr.org.au as ACTRN12609000215224.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Plot of observed red blood cell (RBC) folate concentrations over time and model-estimated lines that were fitted to the data with the use of nonlinear regression, allowing for separate plateaus for each intervention group but with the assumption of the same rate constant (k) for both treatment groups. Placebo (A), 140-μg folic acid/d (B), and 400-μg folic acid/d (C) groups.

Similar articles

Cited by

References

    1. MRC Vitamin Study Research Group Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131–7 - PubMed
    1. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832–5 - PubMed
    1. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999;341:1485–90 - PubMed
    1. Mosley BS, Cleves MA, Siega-Riz AM, et al. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol 2009;169:9–17 - PMC - PubMed
    1. Mills JL, Carter TC. Invited commentary: preventing neural tube defects and more via food fortification? Am J Epidemiol 2009;169:18–21, discussion 22–3 - PMC - PubMed

Publication types